ENTITY

Cellid (299660 KS)

22
Analysis
Health CareSouth Korea
Cellid, Co., Ltd. develops biotechnology. The Company develops innovative immunotherapeutic vaccines, immunology and molecular biology technology, and other related products. Cellid also manufactures and distributes pharmaceuticals and functional foods.
more
Refresh
bullishCellid
15 Jun 2022 22:56

Cellid (299660 KS): Promising Immunotherapeutic Platform; Well-Funded to Commercialize Pipeline

Cellid's lead anticancer vaccine candidate is undergoing a phase 2 trial. Its approval should open multi-billion-dollar market opportunity. Its...

Logo
329 Views
Share
bullishHana Micron Inc
24 May 2022 19:21

KOSDAQ150 Index Rebalance Preview: A Dozen Changes in June

There are 12 adds/deletes for the KOSDAQ150 in June. Most of the inclusions were expected while there appears to be discretion used in choosing the...

Logo
394 Views
Share
13 May 2022 07:27

Alpha Generating Trading Strategy of KOSDAQ150 Deletions & Additions in June 2022

An alpha generating trading strategy would be to focus on companies with higher probability of getting deleted in the next round of KOSDAQ...

Logo
286 Views
Share
bullishGOLFZON
02 May 2022 05:12

KOSDAQ150 Index Rebalance Preview: 14 Potential Changes in June

We forecast 14 potential changes to the KOSDAQ150 Index in June - most are high probability. Short interest on few potential deletions exceeds the...

Logo
522 Views
Share
bullishDanal Co Ltd
11 Apr 2022 15:18

KOSDAQ 150 Rebalancing in June: Safely Tradable Names for Position Buildups at This Point

This post screens the tradable stocks for Long/Short position buildups for the KOSDAQ 150 rebalancing, which will occur on the second Thursday in...

Logo
325 Views
Share
x